Brandi Simpson

Brandi Simpson has a diverse work experience spanning multiple industries and roles. Brandi currently holds the position of Vice President, Business and Corporate Development at Voyager Therapeutics, Inc. since November 2020. Before joining Voyager Therapeutics, Inc., Brandi served as the CEO of Navigen, Inc. from April 2014 to March 2020, where they led the discovery and development of therapeutics composed of D-peptides. Prior to their role as CEO, they were the Chief Business Officer at Navigen, Inc. from June 2007 to April 2014.

Brandi also has experience in the pharmaceutical industry, having worked at NPS Pharmaceuticals. Brandi held the positions of Senior Director, Investor Relations from November 2005 to June 2007 and Senior Director, Corporate Development from November 2002 to November 2005. Prior to these roles, they worked as a Senior Associate at Booz Allen & Hamilton from September 1997 to March 2002.

Brandi began their career as a Summer Associate at Arthur D Little in 1996. Brandi then worked as an Investment Banking Analyst at Merrill Lynch from 1993 to 1995. Additionally, they volunteered as a Community Action Committee Volunteer at United Way of America from 1991 to 1992.

Overall, Brandi Simpson has a wealth of experience in business and corporate development, leadership, investor relations, and strategic consulting across various sectors.

Brandi Simpson completed their MBA from Stanford University Graduate School of Business from 1995 to 1997. Prior to that, they obtained a Bachelor of Science in Finance from the University of Utah - David Eccles School of Business, where they studied from 1989 to 1993. Their education journey began at Blackfoot High School, where they attended from 1984 to 1989.